by Samsara@8529 | Oct 13, 2022 | Home, News
News Article CMT Research Foundation and Samsara Therapeutics Partner on a Novel Therapeutic Approach for CMT1A with the Potential to Reach Clinical Trials ATLANTA, GA and OXFORD, UK (October 13, 2022) The CMT Research Foundation (CMTRF), a non-profit focused... by Samsara@8529 | Jan 5, 2022 | Home, News
News Article Samsara Therapeutics Establishes Scientific Advisory Board Michael Schlossmacher, Susan Perlman, Ed Tate and Christian Behl to help advance development of neurodegeneration and rare genetic disease therapeutics Oxford, UK and Boston, US, 06 January... by Samsara@8529 | Dec 29, 2021 | Home, News
Insights / News Article More additions to the Samsara Therapeutics team Dec 01, 2021 We’re pleased to report that we’ve further strengthened our team in Oxford. Matthew Williamson is an expert in stem cells and patient-derived assays for Parkinson’s Disease, an... by Samsara@8529 | Jun 7, 2021 | Home, News
Insights / News Article New home and strengthening our scientific team June 02, 2021 June 02, 2021 — It’s a busy time for Samsara Therapeutics as we move into our new purpose-built labs and offices in the Wood Centre for Innovation in Oxford. This is a brand new... by Samsara@8529 | Dec 20, 2019 | Home, News
Insights / News Article Samsara Therapeutics Receives $3.2 Million Seed Funding for Further Pipeline Expansion Dec 20, 2019 December 20, 2019 — Samsara Therapeutics Inc, a biotechnology startup with the world’s largest platform for the discovery and development of...